drugset / Trial / NCT05369533

Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

NCT05369533

Phase 1/2 Completed 25 enrolled University of California, Los Angeles
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study explores the effects of telerehabilitation and a study medication on rehabilitation outcomes in patients with stroke resulting in arm weakness. Patients with arm weakness due to a stroke that happened in the past 30 days will be randomized into one of three groups: \[1\] TR and placebo (a sugar pill) on top of usual care; \[2\] TR and a medication (Sinemet 25/100) on top of usual care; \[3\] or usual care alone (no TR and no pill, but people in this group will be offered TR once the study is done). TR consists of 70 minutes/day of activities targeting arm function, 6 days a week for 6 weeks.

Timeline

Start
2022-08-01
Primary completion
2024-03-11
Completion
2024-03-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levodopa Small molecule

Indications